This title is printed to order. This book may have been self-published. If so, we cannot guarantee the quality of the content. In the main most books will have gone through the editing process however some may not. We therefore suggest that you be aware of this before ordering this book. If in doubt check either the author or publisher’s details as we are unable to accept any returns unless they are faulty. Please contact us if you have any questions.
Today, over 420,000 childhood cancer survivors (CCS) are alive in the United States, and
one in 750 individuals in the United States is a survivor of childhood cancer [1]. Despite these
successes, the lifetime disease burden remains inordinately high for CCS [2-4]. Compared to
their healthy siblings, it is estimated that CCS have a 15-fold increase in risk for primary and
secondary cancers, a 15-fold increase in risk for congestive heart failure, an 11-fold increase in
risk for coronary artery disease, a 10-fold increase in risk for stroke, and a 9-fold increase in risk
for kidney failure [2]. Compared to the general population, it is estimated that CCS have a 3.5-
fold increase in risk for metabolic syndrome [5], 2.4-fold increase in risk for obesity, and up to
13-fold increase in risk for diabetes mellitus [6]. Other significant risks remain for chronic
fatigue [7], osteopenia/osteoporosis [8], and early aging [9, 10]. In a recent study of adult
survivors of acute lymphoblastic leukemia, 64% of survivors were found to be insulin resistant
[4], a significant determinant of many serious chronic illnesses for which CCS are at risk [5, 11].
Recently, it has been estimated that by age 45 the predicted cumulative prevalence among CCS is
95.5% for any chronic health condition, and 80.5% for a life-threatening health condition [12].
The health problems facing CCS are lifelong, increase with age, and can result in early mortality
